Research Article

Antidiabetic Activity of Benzopyrone Analogues in Nicotinamide-Streptozotocin Induced Type 2 Diabetes in Rats

Figure 3

Effect of test compounds on serum lipids in nicotinamide-STZ rats; (a) TG, (b) TC, (c) HDL, (d) LDL, (e) VLDL (f) TC/DHL-ratio; G1: normal control; G2: diabetic control (nicotinamide + STZ); G3: diabetic + glibenclamide (2.5 mg/kg); G4: diabetic + quercetin (10 mg/kg); G5: diabetic + JY-1; G6: diabetic + JY-2; G7: Diabetic + JY-3; G8: diabetic + JY-4; (test compounds at optimised dose of 80 mg/kg); all values mean ± SEM (); compared to normal control (G1), compared to diabetic control (G2) (one-way ANOVA followed by Tukey’s post-hoc test).
(a)
(b)
(c)
(d)
(e)
(f)